Product
CXCR4-TSB
BIOTECHNOLOGY
byCardivia Labs Inc
United States (US)
ABOUT THE PRODUCT
A Target-Site Blocker (TSB) targeting CXCR4, designed to reprogram endothelial and smooth muscle cells to combat atherosclerosis.
Information is owner-confirmed
Last updated 2 months ago
Price range